不良事件报告系统
贝伐单抗
医学
药物警戒
不利影响
优势比
内科学
数据库
肿瘤科
化疗
计算机科学
作者
Linlin Tang,Chuanhua Ding,Hongying Li,Guoqiang Yin,Haixia Zhang,Wen Shan Liu,Yinghui Ji,Hui Li
标识
DOI:10.1080/14740338.2023.2248876
摘要
The AE report from the present study confirms the majority of label information for bevacizumab, while also identifying new AEs. In addition, this was a large descriptive study of bevacizumab-induced hemorrhage.
科研通智能强力驱动
Strongly Powered by AbleSci AI